The primary objective of this study is to determine whether intracoronary infusion of autologous mononuclear bone marrow cells or peripheral mononuclear blood cells provides improved recovery of regional left ventricular function after an acute,…
ID
Bron
Verkorte titel
Aandoening
Acute myocardial infarction
Ondersteuning
Onderzoeksproduct en/of interventie
Uitkomstmaten
Primaire uitkomstmaten
The change of regional myocardial function based on a MRI-segmental analysis at 4 months relative to baseline.
Achtergrond van het onderzoek
N/A
Doel van het onderzoek
The primary objective of this study is to determine whether intracoronary infusion of autologous mononuclear bone marrow cells or peripheral mononuclear blood cells provides improved recovery of regional left ventricular function after an acute, large myocardial infarction treated by PCI compared to standard therapy.
Onderzoeksopzet
N/A
Onderzoeksproduct en/of interventie
After written informed consent has been obtained, MRI measurements and echocardiography are performed minimally 48 hours after PCI. Patients are randomized to a treatment with
1. Intracoronary infusion of autologous mononuclear bone marrow cells;
2. Intracoronary infusion of peripheral mononuclear blood cells; or
3. Standard therapy.
If applicable, bone marrow is aspirated from the iliac crest under local anesthesia or venous blood is collected. Mononuclear cells are isolated from the aspirate or blood by density gradient centrifugation. Within 7 days after PCI and within 24 hours after bone marrow aspiration or venous blood collection, a catheterization for the intracoronary infusion of the autologous mononuclear cells in the infarct related coronary artery is performed. In all patients the follow up is at 1, 4 and 12 months.
The MRI measurements and catheterization are repeated at 4 months.
Algemeen / deelnemers
Department of Cardiology,
P.O. Box 22660
J.J. Piek
Meibergdreef 9
Amsterdam 1100 DD
The Netherlands
+31 (0)20 5663072
j.j.piek@amc.uva.nl
Wetenschappers
Department of Cardiology,
P.O. Box 22660
J.J. Piek
Meibergdreef 9
Amsterdam 1100 DD
The Netherlands
+31 (0)20 5663072
j.j.piek@amc.uva.nl
Belangrijkste voorwaarden om deel te mogen nemen (Inclusiecriteria)
1. PCI within 12 hours of onset of symptoms;
2. Successful treatment of a culprit lesion in the LAD, RCA or RCX;
3. At least one CK and/or CK-MB measurement 10 times higher than the local ULN;
4. hypokinesia or akinesia of >=3 segments using a 16-segment model documented by routine resting echocardiography at least 12 hours after primary PCI;
5. Clinically and hemodynamically stable over the previous 12 hours.
Belangrijkste redenen om niet deel te kunnen nemen (Exclusiecriteria)
1. <30 or >70 years of age;
2. Anticipated percutaneous or surgical coronary intervention within the next 4 months;
3. Presence of supraventricular or ventricular arrhythmias;
4. LV ejection fraction < 45% prior to current admission for myocardial infarction;
5. Stroke or transient ischemic attack within the previous 24 hours;
6. Any contraindication for MRI;
7. Positive for HIV, HBV or HCV infection;
8. Serious known concomitant disease with a life expectancy of less than one year.
Opzet
Deelname
Opgevolgd door onderstaande (mogelijk meer actuele) registratie
Geen registraties gevonden.
Andere (mogelijk minder actuele) registraties in dit register
Geen registraties gevonden.
In overige registers
| Register | ID |
|---|---|
| NTR-new | NL132 |
| NTR-old | NTR166 |
| Ander register | : N/A |
| ISRCTN | ISRCTN95796863 |